Heinemann Mitja L, Ilmer Matthias, Silva Leslie P, Hawke David H, Recio Alejandro, Vorontsova Maria A, Alt Eckhard, Vykoukal Jody
Department of Translational Molecular Pathology, Unit 2951, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard,Houston, TX 77030, USA
J Chromatogr A. 2014 Dec 5;1371:125-35. doi: 10.1016/j.chroma.2014.10.026.
Early and minimally invasive detection of malignant events or other pathologies is of utmost importance in the pursuit of improved patient care and outcomes. Recent evidence indicates that exosomes and extracellular vesicles in serum and body fluids can contain nucleic acid, protein, and other biomarkers. Accordingly, there is great interest in applying these clinically as prognostic, predictive, pharmacodynamic, and early detection indicators. Nevertheless, existing exosome isolation methods can be time-consuming, require specialized equipment, and/or present other inefficiencies regarding purity, reproducibility and assay cost. We have developed a straightforward, three-step protocol for exosome isolation of cell culture supernatants or large volumes of biofluid based on sequential steps of dead-end pre-filtration, tangential flow filtration (TFF), and low-pressure track-etched membrane filtration that we introduce here. Our approach yields exosome preparations of high purity and defined size distribution and facilitates depletion of free protein and other low-molecular-weight species, extracellular vesicles larger than 100nm, and cell debris. Samples of exosomes prepared using the approach were verified morphologically by nanoparticle tracking analysis and electron microscopy, and mass spectrometry analyses confirmed the presence of previously reported exosome-associated proteins. In addition to being easy-to-implement, sequential filtration yields exosomes of high purity and, importantly, functional integrity as a result of the relatively low-magnitude manipulation forces employed during isolation. This answers an unmet need for preparation of minimally manipulated exosomes for investigations into exosome function and basic biology. Further, the strategy is amenable to translation for clinical exosome isolations because of its speed, automatability, scalability, and specificity for isolating exosomes from complex biological samples.
在追求改善患者护理和治疗结果的过程中,早期和微创检测恶性事件或其他病理状况至关重要。最近的证据表明,血清和体液中的外泌体和细胞外囊泡可含有核酸、蛋白质和其他生物标志物。因此,人们对将这些物质临床应用于预后、预测、药效学和早期检测指标有着浓厚的兴趣。然而,现有的外泌体分离方法可能耗时、需要专门设备,和/或在纯度、可重复性和检测成本方面存在其他低效问题。我们基于死端预过滤、切向流过滤(TFF)和低压径迹蚀刻膜过滤的连续步骤,开发了一种简单的三步方案,用于从细胞培养上清液或大量生物流体中分离外泌体,我们在此介绍该方案。我们的方法可产生高纯度且大小分布明确的外泌体制剂,并有助于去除游离蛋白质和其他低分子量物质、大于100nm的细胞外囊泡以及细胞碎片。使用该方法制备的外泌体样本通过纳米颗粒跟踪分析和电子显微镜进行了形态学验证,质谱分析证实了先前报道的外泌体相关蛋白的存在。除了易于实施外,连续过滤还能产生高纯度的外泌体,重要的是,由于在分离过程中采用的操作力相对较小,外泌体具有功能完整性。这满足了制备经过最少操作的外泌体以用于外泌体功能和基础生物学研究的未满足需求。此外,该策略因其速度、可自动化性、可扩展性以及从复杂生物样本中分离外泌体的特异性,适合转化用于临床外泌体分离。